论文信息 - Final overall survival results of a randomized phase III trial comparing weekly docetaxel plus cisplatin (DP) with 3-weekly docetaxel (D) monotherapy in elderly patients (pts) with advanced non-small-cell lung cancer (NSCLC): intergroup trial JCOG0803/WJOG4307L. - 字舞流文

Final overall survival results of a randomized phase III trial comparing weekly docetaxel plus cisplatin (DP) with 3-weekly docetaxel (D) monotherapy in elderly patients (pts) with advanced non-small-cell lung cancer (NSCLC): intergroup trial JCOG0803/WJOG4307L.

N. Saijo | Y. Ichinose | Y. Ohe | H. Saka | M. Ando | S. Kudoh | Shinichiro Nakamura | Y. Iwamoto | N. Yamamoto | T. Tamura | K. Nakagawa | K. Takeda | H. Yoshioka | J. Mizusawa | T. Mizutani | T. Sawa | H. Okamoto | T. Abe | A. Yokoyama | K. Minato